CVE-2025-70327

Exploitation

Public exploit code exists. CISA's assessment records a public proof of concept. That is not a report of exploitation in the wild.

SSVC decision

• ExploitationpocPublic proof-of-concept exploit code exists. Not a report of exploitation in the wild.
• AutomatableyesAn attacker can reliably automate reconnaissance through exploitation, so this scales.
• Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.69% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 50.3% of scored records. A rank, not a probability.

NVD base score

9.8 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

NVD analysis status

Analyzed. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2026-02-23 00:00Z6 MO AGO

Last updated

2026-02-25 14:32Z6 MO AGO

Reserved

2026-01-09

Assigning CNA

mitre

Record state

PUBLISHED

Severity

Critical (CVSS 9.8)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Weaknesses

• CWE-400Uncontrolled Resource ConsumptionClass
• CWE-88Improper Neutralization of Argument Delimiters in a Command ('Argument Injection')Base

Data version

5.2

Document digest

7cc8568f444a183c0d70ad1e3351c01563850ab2e07b5a04e53218eede1f1400

• www.notion.sohttps://www.notion.so/TOTOLINK-X5000R-SetDiagnosisCfg-2d170566ca7f8098a0bcee9f2a15d40d?source=copy_link
• github.comhttps://github.com/neighborhood-H/0-DAY/blob/main/Toto-link/X5000R/SetDiagnosisCfg/report.md